scholarly journals Labelled leucocyte scintigraphy in inflammatory bowel disease: clinical applications.

Gut ◽  
1996 ◽  
Vol 38 (1) ◽  
pp. 1-5 ◽  
Author(s):  
M H Giaffer
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Clinical Applications ◽  
Leucocyte Scintigraphy ◽  
Inflammatory Bowel

scholarly journals Indium-111 leucocyte scintigraphy in the investigation and management of inflammatory bowel disease.

1986 ◽  
Vol 62 (728) ◽  
pp. 457-462 ◽  
Author(s):  
K. J. Fotherby ◽  
E. P. Wraight ◽  
H. Garforth ◽  
J. O. Hunter
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Leucocyte Scintigraphy ◽  
Indium 111 ◽  
Inflammatory Bowel

Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications

1983 ◽  
Vol 14 (11) ◽  
pp. 931-968 ◽  
Author(s):  
Robert H. Riddell ◽  
Harvey Goldman ◽  
David F. Ransohoff ◽  
Henry D. Appelman ◽  
Cecilia M. Fenoglio ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Clinical Applications ◽  
Inflammatory Bowel

scholarly journals Evolving Technologies in Gastrointestinal Microbiome Era and Their Potential Clinical Applications

2020 ◽  
Vol 9 (8) ◽  
pp. 2565
Author(s):  
Abraham Ajayi ◽  
Tolulope Jolaiya ◽  
Stella Smith
Keyword(s):  
Metabolic Syndrome ◽  
Inflammatory Bowel Disease ◽  
Clinical Practice ◽  
Bowel Disease ◽  
Clinical Applications ◽  
Routine Clinical Practice ◽  
Gastrointestinal Microbiota ◽  
Gastrointestinal Microbiome ◽  
Medical Interventions ◽  
Inflammatory Bowel

The human gastrointestinal microbiota (GIM) is a complex and diverse ecosystem that consists of community of fungi, viruses, protists and majorly bacteria. The association of several human illnesses, such as inflammatory bowel disease, allergy, metabolic syndrome and cancers, have been linked directly or indirectly to compromise in the integrity of the GIM, for which some medical interventions have been proposed or attempted. This review highlights and gives update on various technologies, including microfluidics, high-through-put sequencing, metabolomics, metatranscriptomics and culture in GIM research and their applications in gastrointestinal microbiota therapy, with a view to raise interest in the evaluation, validation and eventual use of these technologies in diagnosis and the incorporation of therapies in routine clinical practice.

Sign in / Sign up

Export Citation Format

Share Document